These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3103169)

  • 1. Effects of 1 gram oral or intravenous aspirin on urinary excretion of thromboxane B2 and 6-keto-PGF1 alpha in healthy subjects.
    Bucchi F; Bodzenta A; de Gaetano G; Cerletti C
    Prostaglandins; 1986 Nov; 32(5):691-701. PubMed ID: 3103169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
    Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
    Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
    Livio M; Benigni A; Zoja C; Begnis R; Morelli C; Rossini M; Garattini S; Remuzzi G
    J Pharmacol Exp Ther; 1989 Jan; 248(1):334-41. PubMed ID: 2492341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rebound elevation in urinary thromboxane B2 and 6-keto-PGF1 alpha excretion after aspirin withdrawal.
    Vial JH; McLeod LJ; Roberts MS
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():157-60. PubMed ID: 1825534
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemical selectivity of oral versus intravenous aspirin in rats. Inhibition by oral aspirin of cyclooxygenase activity in platelets and presystemic but not systemic vessels.
    Cerletti C; Gambino MC; Garattini S; de Gaetano G
    J Clin Invest; 1986 Jul; 78(1):323-6. PubMed ID: 3088044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
    Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
    Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry.
    Chiabrando C; Pinciroli V; Campoleoni A; Benigni A; Piccinelli A; Fanelli R
    J Chromatogr; 1989 Oct; 495():1-11. PubMed ID: 2613794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of aspirin on thromboxane and prostaglandin biosynthesis in man.
    Ritter JM; Cockcroft JR; Doktor HS; Beacham J; Barrow SE
    Br J Clin Pharmacol; 1989 Nov; 28(5):573-9. PubMed ID: 2590611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectivity of oral aspirin as an inhibitor of platelet vs. vascular cyclooxygenase activity is reduced by portacaval shunt in rats.
    Gambino MC; Passaghe S; Chen ZM; Bucchi F; Gori G; Latini R; de Gaetano G; Cerletti C
    J Pharmacol Exp Ther; 1988 Apr; 245(1):287-90. PubMed ID: 3129553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of oral and intravenous aspirin administration on platelet and peripheral vascular cyclo-oxygenase activity: studies in rats and in man.
    Cerletti C; Gambino MC; Bucchi F; Rajtar G; Riva E; de Goetano G
    Agents Actions Suppl; 1986; 20():239-48. PubMed ID: 3101444
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased prostacyclin production during exercise in untrained and trained men: effect of low-dose aspirin.
    Böger RH; Bode-Böger SM; Schröder EP; Tsikas D; Frölich JC
    J Appl Physiol (1985); 1995 May; 78(5):1832-8. PubMed ID: 7649919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular thromboxane formation in hemostasis mechanism: correlation between bleeding time and vascular TXB2 in a patient with congenital platelet cyclo-oxygenase deficiency.
    Fuse I; Ootsuka T; Hattori A; Mito M; Shibata A
    Int J Hematol; 1996 Jun; 63(4):317-24. PubMed ID: 8762815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal modification of platelet function. A dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesis.
    Keimowitz RM; Pulvermacher G; Mayo G; Fitzgerald DJ
    Circulation; 1993 Aug; 88(2):556-61. PubMed ID: 8339418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of platelet cyclooxygenase with controlled release, low-dose aspirin.
    Vial JH; McLeod LJ; Roberts MS; Seville PR
    Aust N Z J Med; 1990 Oct; 20(5):652-6. PubMed ID: 2126726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man.
    Rosenkranz B; Fischer C; Meese CO; Frölich JC
    Br J Clin Pharmacol; 1986 Mar; 21(3):309-17. PubMed ID: 3083851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of low doses of aspirin, 10 mg and 30 mg daily, on bleeding time, thromboxane production and 6-keto-PGF1 alpha excretion in healthy subjects.
    Kallmann R; Nieuwenhuis HK; de Groot PG; van Gijn J; Sixma JJ
    Thromb Res; 1987 Feb; 45(4):355-61. PubMed ID: 3576521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation.
    Lupinetti MD; Sheller JR; Catella F; Fitzgerald GA
    Am Rev Respir Dis; 1989 Oct; 140(4):932-5. PubMed ID: 2508524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered renal and platelet arachidonic acid metabolism in cirrhosis.
    Laffi G; La Villa G; Pinzani M; Ciabattoni G; Patrignani P; Mannelli M; Cominelli F; Gentilini P
    Gastroenterology; 1986 Feb; 90(2):274-82. PubMed ID: 3079716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo measurement of thromboxane B2 and 6-keto-prostaglandin F1 alpha in humans in response to a standardized vascular injury and the influence of aspirin.
    Gerrard JM; Taback S; Singhroy S; Docherty JC; Kostolansky I; McNicol A; Kobrinsky NL; McKenzie JK; Rowe R
    Circulation; 1989 Jan; 79(1):29-38. PubMed ID: 2910545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of two low doses of aspirin on whole blood thromboxane and prostacyclin generation in healthy subjects.
    Davì G; Custro N; Novo S; Mattina A; Strano A
    Thromb Haemost; 1983 Oct; 50(3):669-70. PubMed ID: 6417815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.